2-Deoxy-D-glucose (Synonyms: 2-DG) |
カタログ番号GC17430 |
2-デオキシ-D-グルコース(2DG)は、グルコースアナログであり、競合的な糖解阻害剤として作用します。
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 154-17-6
Sample solution is provided at 25 µL, 10mM.
Quality Control & SDS
- View current batch:
- Purity: >98.00%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Cell experiment [1]: | |
Cell lines |
Cell lines SkBr3, MCF-7, BT474, and MDA/MB468, |
Preparation Method |
Cells were plated at 4000 cells well-1 in a 96-well plate, allowed 24 h to attach and subsequently exposed for 4 days to 2-Deoxy-D-glucose. |
Reaction Conditions |
4-12 mM for 0-4 days |
Applications |
Growth of MDA/MB468 cells was completely inhibited by treatment with 8 mM 2-Deoxy-D-glucose. Treatment with 4 mM 2-Deoxy-D-glucose resulted in approximately 30% inhibition of cell growth. Of the breast cancer cell lines tested, SkBr3 was the most sensitive to the growth inhibitory effects of 2-Deoxy-D-glucose. Cell growth was completely inhibited at 4 mM 2-Deoxy-D-glucose. |
Animal experiment [2]: | |
Animal models |
male Sprague-Dawley (SD) rats |
Preparation Method |
Animals were handled routinely in order to reduce stress associated with injection. 2-deoxy-d-glucose (400 mg/kg), or saline, was administered intraperitoneally. |
Dosage form |
Intraperitoneal injection , 400 mg/kg |
Applications |
Ad concentrations increased from 2.73 ng/ml to 7.2 ng/ml while NAd concentrations increased from 1.8 ng/ml to 3.14 ng/ml after injected 2-deoxy-d-glucose. |
References: [1]: Aft R L, Zhang F W, Gius D. Evaluation of 2-deoxy-D-glucose as a chemotherapeutic agent: mechanism of cell death[J]. British journal of cancer, 2002, 87(7): 805-812. |
2-デオキシ-D-グルコース(2DG)は、競合的な糖解阻害剤として機能するグルコースアナログです[1]。
2-デオキシ-D-グルコース(2DG)は、がん細胞における糖代謝の増加を阻害し、調査するための強力な薬剤であることが示されています[2]。グルコースに類似しているため、2-デオキシ-D-グルコースは解糖系を抑制しますが、化学的には2-デオキシマンノースでもあります。そのため、Nリンク型グリコシル化の初期段階で成長中の脂質結合オリゴ糖鎖内でマンノースと競合することができます。このようなマンノース様性質により、2-デオキシ-D-グルコースは誤った折り畳みタンパク質を引き起こし、小胞体ストレス[3]を引き起こします。
食事中に投与された2-デオキシ-D-グルコースは、0.02〜0.3 g/kg(食事中の重量で0.04〜0.6%の2-デオキシ-D-グルコース)の用量範囲でラットの心毒性を引き起こし、0.2 g/kg(食事中の重量で0.4%)以上では死亡率を早めます[4]。 20分と60分後に血漿アドレナリンとグルコースが増加するようになりました[5]。
References:
[1]. MÜhlenberg T, Grunewald S, Treckmann J, et al. Inhibition of KIT-glycosylation by 2-deoxyglucose abrogates KIT-signaling and combination with ABT-263 synergistically induces apoptosis in gastrointestinal stromal tumor[J]. PloS one, 2015, 10(3): e0120531.
[2]. El Mjiyad N, Caro-Maldonado A, Ramirez-Peinado S, Munoz-Pinedo C. Sugar-free approaches to cancer cell killing. Oncogene. 2011 Jan;30(3):253-64.
[3]. Kurtoglu, Metin, Johnathan C. Maher, and Theodore J. Lampidis. "Differential toxic mechanisms of 2-deoxy-D-glucose versus 2-fluorodeoxy-D-glucose in hypoxic and normoxic tumor cells." Antioxidants & redox signaling 9.9 (2007): 1383-1390.
[4]. Minor R K, Smith Jr D L, Sossong A M, et al. Chronic ingestion of 2-deoxy-D-glucose induces cardiac vacuolization and increases mortality in rats[J]. Toxicology and applied pharmacology, 2010, 243(3): 332-339.
[5]. Bobrovskaya L, Damanhuri H A, Ong L K, et al. Signal transduction pathways and tyrosine hydroxylase regulation in the adrenal medulla following glucoprivation: an in vivo analysis[J]. Neurochemistry international, 2010, 57(2): 162-167.
Cas No. | 154-17-6 | SDF | |
同義語 | 2-DG | ||
Chemical Name | (4R,5S,6R)-6-(hydroxymethyl)tetrahydro-2H-pyran-2,4,5-triol | ||
Canonical SMILES | [H][C@]([C@](C1([H])[H])([H])O[H])([C@](C([H])([H])O[H])([H])OC1([H])O[H])O[H] | ||
Formula | C6H12O5 | M.Wt | 164.16 |
溶解度 | DMF: 10 mg/ml,DMSO: 20 mg/ml,PBS (pH 7.2): 10 mg/ml | Storage | Store at -20°C |
General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. |
Prepare stock solution | |||
1 mg | 5 mg | 10 mg | |
1 mM | 6.0916 mL | 30.4581 mL | 60.9162 mL |
5 mM | 1.2183 mL | 6.0916 mL | 12.1832 mL |
10 mM | 0.6092 mL | 3.0458 mL | 6.0916 mL |
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Average Rating: 5
(Based on Reviews and 35 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *